Cyclacel Pharmaceuticals Statistics

Total Valuation

CYCC has a market cap or net worth of $2.44 million. The enterprise value is -$333,356.

Market Cap	2.44M
Enterprise Value	-333,356

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

CYCC has 1.46 million shares outstanding. The number of shares has increased by 57.70% in one year.

Shares Outstanding	1.46M
Shares Change (YoY)	+57.70%
Shares Change (QoQ)	+56.40%
Owned by Insiders (%)	7.36%
Owned by Institutions (%)	22.71%
Float	1.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.44
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.58

Current Ratio	0.58
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,013.40%.

Return on Equity (ROE)	-1,013.40%
Return on Assets (ROA)	-180.80%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$37,417
Profits Per Employee	-$1.65M
Employee Count	12
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	-3.03M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.51% in the last 52 weeks. The beta is 0.59, so CYCC's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-85.51%
50-Day Moving Average	1.92
200-Day Moving Average	3.35
Relative Strength Index (RSI)	47.20
Average Volume (20 Days)	111,053

Short Selling Information

The latest short interest is 167,309, so 11.43% of the outstanding shares have been sold short.

Short Interest	167,309
Short Previous Month	154,701
Short % of Shares Out	11.43%
Short % of Float	14.51%
Short Ratio (days to cover)	0.69

Income Statement

In the last 12 months, CYCC had revenue of $449,000 and -$19.85 million in losses. Loss per share was -$22.05.

Revenue	449,000
Gross Profit	449,000
Operating Income	-22.49M
Pretax Income	-22.73M
Net Income	-19.85M
EBITDA	-22.70M
EBIT	-22.73M
Loss Per Share	-$22.05

Full Income Statement

Balance Sheet

The company has $2.80 million in cash and $21,000 in debt, giving a net cash position of $2.78 million or $1.90 per share.

Cash & Cash Equivalents	2.80M
Total Debt	21,000
Net Cash	2.78M
Net Cash Per Share	$1.90
Equity (Book Value)	-2.21M
Book Value Per Share	-1.51
Working Capital	-3.52M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-9.73M
Capital Expenditures	n/a
Free Cash Flow	-9.73M
FCF Per Share	-$7.38

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -5,008.69% and -4,420.27%.

Gross Margin	100.00%
Operating Margin	-5,008.69%
Pretax Margin	-5,061.69%
Profit Margin	-4,420.27%
EBITDA Margin	-5,056.12%
EBIT Margin	-5,061.69%
FCF Margin	-2,167.93%

Dividends & Yields

CYCC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.70%
Shareholder Yield	-57.70%
Earnings Yield	-812.19%
FCF Yield	-398.34%

Dividend Details

Analyst Forecast

The average price target for CYCC is $11.00, which is 558.68% higher than the current price. The consensus rating is "Buy".

Price Target	$11.00
Price Target Difference	558.68%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	229.49%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 18, 2023. It was a reverse split with a ratio of 1:15.

Last Split Date	Dec 18, 2023
Split Type	Reverse
Split Ratio	1:15

Scores

CYCC has an Altman Z-Score of -110.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-110.53
Piotroski F-Score	2